| 書目名稱 | Targeting Oral Cancer | | 編輯 | Andrew M. Fribley | | 視頻video | http://file.papertrans.cn/901/900640/900640.mp4 | | 概述 | Provides up-to-date information on the oral cancer patient population and treatment options.Examines the value of a variety of biomarkers.Describes breaking developments and new drug discoveries | | 圖書封面 |  | | 描述 | This book provides research-oriented care providers with up-to-date information on the oral cancer patient population, the ways in which we are treating them, and the scientific approaches being pursued in order to improve survival and reduce treatment-related morbidity. The text is organized into three sections covering epidemiology and management, cancer development and biomarkers, and breaking developments and novel approaches for drug discovery. The first section includes discussion of the emerging role of HPV in oral cancer and explains the surgical, chemotherapy and radiation approaches to treatment. Aspects such as molecular progression, the role of cancer stem cells in tumor development, and the value of various biomarkers are then examined. The final section is devoted to the latest advances and covers, among other topics, current clinical trials, emerging drug targets, and targeting of the unfolded protein response and of mediators of coagulation. | | 出版日期 | Book 2016 | | 關(guān)鍵詞 | Biomarkers; Cancer Stem Cells; Chemotherapy; Human Papillomavirus; Surgical Management; Molecular Signali | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-319-27647-2 | | isbn_softcover | 978-3-319-80192-6 | | isbn_ebook | 978-3-319-27647-2 | | copyright | Springer International Publishing Switzerland 2016 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-5 21:27
發(fā)表于 2025-3-21 16:22:59
